Profile data is unavailable for this security.
About the company
Double Bond Pharmaceutical International AB (publ) is a Sweden- based pharmaceutical company primarily engaged in manufacturing of pharmaceuticals, operations in medical technology and other related activities. The Company scope of activity revolves around developing medicinal products for patients suffering from diseases such as cancer, inflammation, asthma as well as diabetes. The Company main focus is on the treatment of severe forms of cancer, infections and autoimmune diseases. The research is based on company's technology. Double Bond Pharmaceutical International AB products are sold under separate trademarks and collaboration on product development is done together with other companies in the field.
- Revenue in SEK (TTM)278.65k
- Net income in SEK-841.63k
- Incorporated2014
- Employees9.00
- LocationDouble Bond Pharmaceutical International AB (publ)Virdings Alle 32 BUPPSALA 754 50SwedenSWE
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lipigon Pharmaceuticals AB | 1.32m | -35.97m | 6.67m | 7.00 | -- | 0.4417 | -- | 5.06 | -0.1317 | -0.1317 | 0.0035 | 0.0249 | 0.0674 | -- | 0.2937 | 188,142.90 | -183.92 | -860.41 | -214.33 | -1,152.75 | -- | -- | -2,731.06 | -1,282.24 | -- | -- | 0.00 | -- | -37.30 | 42.64 | 74.22 | -- | -- | -- |
| Double Bond Phrmcutcl Intrntnl AB (publ) | 278.65k | -841.63k | 25.49m | 9.00 | -- | 2.13 | -- | 91.48 | -0.02 | -0.02 | 0.0035 | 0.056 | 0.027 | -- | 2.99 | 30,961.11 | -8.16 | -75.46 | -11.26 | -104.36 | 2,263.63 | -717.21 | -302.04 | -1,144.39 | -- | 0.78 | 0.00 | -- | -20.52 | 35.18 | 58.98 | -- | 114.06 | -- |
| Pila Pharma AB | 957.89k | -11.26m | 50.50m | 0.00 | -- | 31.49 | -- | 52.72 | -0.3702 | -0.3702 | 0.0315 | 0.0381 | 0.2406 | -- | 7.20 | -- | -282.78 | -113.42 | -602.96 | -128.21 | -679.51 | -118.10 | -1,175.22 | -1,491.09 | -- | -136.10 | 0.00 | -- | -47.03 | 17.47 | -13.21 | -- | -- | -- |
| ExpreS2ion Biotech Holding AB | 10.85m | -45.17m | 56.34m | 20.00 | -- | 1.27 | -- | 5.19 | -44.22 | -44.22 | 5.14 | 12.52 | 0.1305 | -- | 5.67 | 571,157.90 | -54.33 | -58.63 | -85.25 | -70.70 | 55.64 | -18.17 | -416.26 | -621.40 | -- | -- | 0.0433 | -- | -11.07 | -10.76 | 60.57 | -- | 5.08 | -- |
| XP Chemistries AB | 311.47k | -7.67m | 57.30m | 2.00 | -- | 1.45 | -- | 183.97 | -0.042 | -0.042 | 0.0017 | 0.126 | 0.0095 | 3.58 | 9.76 | 155,735.00 | -23.42 | -- | -25.03 | -- | -1,850.65 | -- | -2,461.64 | -- | 17.17 | -- | 0.00 | -- | -57.22 | -- | 11.26 | -- | -- | -- |
| Odi Pharma AB (publ) | 8.97m | -4.72m | 67.09m | 1.00 | -- | 229.33 | -- | 7.48 | -0.2851 | -0.2851 | 0.5266 | 0.016 | 1.33 | -- | 5.29 | 8,971,460.00 | -70.09 | -40.68 | -1,151.76 | -60.97 | -29.08 | -- | -52.61 | -95.17 | -- | -8.51 | 0.00 | -- | -85.94 | -- | -944.49 | -- | -- | -- |
| Oncozenge AB | 2.71m | -8.56m | 71.46m | 1.00 | -- | 7.68 | -- | 26.34 | -0.7136 | -0.7136 | 0.2282 | 0.7357 | 0.162 | -- | 3.75 | 2,713,000.00 | -51.09 | -- | -58.48 | -- | -- | -- | -315.33 | -- | -- | -610.07 | 0.4463 | -- | -- | -- | 45.37 | -- | -- | -- |
| Arctic Bioscience AS | 41.26m | -40.69m | 87.79m | 22.00 | -- | 0.4772 | -- | 2.13 | -1.67 | -1.67 | 1.69 | 7.27 | 0.156 | 0.9957 | 4.02 | 1,998,510.00 | -15.39 | -15.49 | -18.84 | -17.83 | 28.45 | 28.52 | -98.62 | -125.49 | 0.3389 | -9.68 | 0.2202 | -- | 28.84 | 7.68 | -5.31 | -- | -- | -- |
| StenoCare A/S | 8.02m | -34.76m | 94.52m | 8.00 | -- | 26.94 | -- | 11.78 | -0.8176 | -0.8176 | 0.1569 | 0.0572 | 0.324 | -- | 3.80 | 709,217.50 | -140.37 | -45.69 | -201.07 | -59.64 | -- | -- | -433.19 | -739.04 | 1.32 | -6.51 | 0.526 | -- | -40.60 | -14.70 | -96.30 | -- | -64.95 | -- |
| Vivesto AB | 0.00 | -35.72m | 103.52m | 4.00 | -- | 0.3875 | -- | -- | -0.0664 | -0.0664 | 0.00 | 0.2483 | 0.00 | -- | -- | 0.00 | -21.35 | -- | -23.62 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 69.12 | -- | -- | -- |
Data as of Feb 12 2026. Currency figures normalised to Double Bond Pharmaceutical International AB (publ)'s reporting currency: Swedish Krona SEK
